# OnCo record tyra-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/tyra-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "tyra-biosciences" ;
  schema:name "Tyra Biosciences"@en ;
  schema:description "Tyra Biosciences designs precise pills against a family of growth-signal proteins called FGFRs, which are faulty in some bladder, liver and bile duct cancers and in a bone growth disorder."@en ;
  schema:url <https://onco.cc/companies/tyra-biosciences/>, <https://tyra.bio/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://tyra.bio/>, <https://tyra.bio/pipeline/>, <https://www.sec.gov/Archives/edgar/data/1863127/000119312521276124/d220261d8k.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/fgfr2/> ;
  onco:drugs <https://onco.cc/drugs/tyra-300/> ;
  onco:trials <https://onco.cc/trials/nct06995677/>, <https://onco.cc/trials/nct05544552/> .